Chapter/Section Purchase

1 Nanoscale Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Nanoscale Drug Delivery Devices
1.2 Nanoscale Drug Delivery Devices Segment by Type
1.2.1 Global Nanoscale Drug Delivery Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Temperature Response Nanoscale Drug Delivery Device
1.2.3 Acid-Base pH Response Nanoscale Drug Delivery Device
1.2.4 Redox Response Nanoscale Drug Delivery Device
1.2.5 Magnetic Field Response Nanoscale Drug Delivery Device
1.2.6 Others
1.3 Nanoscale Drug Delivery Devices Segment by Application
1.3.1 Global Nanoscale Drug Delivery Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Nanoscale Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Nanoscale Drug Delivery Devices Revenue 2017-2028
1.4.2 Global Nanoscale Drug Delivery Devices Sales 2017-2028
1.4.3 Nanoscale Drug Delivery Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Nanoscale Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Nanoscale Drug Delivery Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Nanoscale Drug Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Nanoscale Drug Delivery Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Nanoscale Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Nanoscale Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Nanoscale Drug Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nanoscale Drug Delivery Devices Players Market Share by Revenue
2.5.3 Global Nanoscale Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nanoscale Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Nanoscale Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Nanoscale Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Nanoscale Drug Delivery Devices Market Facts & Figures by Country
3.3.1 North America Nanoscale Drug Delivery Devices Sales by Country
3.3.2 North America Nanoscale Drug Delivery Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Nanoscale Drug Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Nanoscale Drug Delivery Devices Sales by Country
3.4.2 Europe Nanoscale Drug Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nanoscale Drug Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Nanoscale Drug Delivery Devices Sales by Region
3.5.2 Asia Pacific Nanoscale Drug Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Nanoscale Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Nanoscale Drug Delivery Devices Sales by Country
3.6.2 Latin America Nanoscale Drug Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Nanoscale Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Nanoscale Drug Delivery Devices Sales by Country
3.7.2 Middle East and Africa Nanoscale Drug Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nanoscale Drug Delivery Devices Historic Market Analysis by Type
4.1 Global Nanoscale Drug Delivery Devices Sales Market Share by Type (2017-2022)
4.2 Global Nanoscale Drug Delivery Devices Revenue Market Share by Type (2017-2022)
4.3 Global Nanoscale Drug Delivery Devices Price by Type (2017-2022)
5 Global Nanoscale Drug Delivery Devices Historic Market Analysis by Application
5.1 Global Nanoscale Drug Delivery Devices Sales Market Share by Application (2017-2022)
5.2 Global Nanoscale Drug Delivery Devices Revenue Market Share by Application (2017-2022)
5.3 Global Nanoscale Drug Delivery Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Lubrizol
6.1.1 Lubrizol Corporation Information
6.1.2 Lubrizol Description and Business Overview
6.1.3 Lubrizol Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Lubrizol Nanoscale Drug Delivery Devices Product Portfolio
6.1.5 Lubrizol Recent Developments/Updates
6.2 West Pharmaceutical Services
6.2.1 West Pharmaceutical Services Corporation Information
6.2.2 West Pharmaceutical Services Description and Business Overview
6.2.3 West Pharmaceutical Services Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 West Pharmaceutical Services Nanoscale Drug Delivery Devices Product Portfolio
6.2.5 West Pharmaceutical Services Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Johnson & Johnson Nanoscale Drug Delivery Devices Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Nanoscale Drug Delivery Devices Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Roche Nanoscale Drug Delivery Devices Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Scios
6.6.1 Scios Corporation Information
6.6.2 Scios Description and Business Overview
6.6.3 Scios Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Scios Nanoscale Drug Delivery Devices Product Portfolio
6.6.5 Scios Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Nanoscale Drug Delivery Devices Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bayer Nanoscale Drug Delivery Devices Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Raritan Pharmaceuticals
6.9.1 Raritan Pharmaceuticals Corporation Information
6.9.2 Raritan Pharmaceuticals Description and Business Overview
6.9.3 Raritan Pharmaceuticals Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Raritan Pharmaceuticals Nanoscale Drug Delivery Devices Product Portfolio
6.9.5 Raritan Pharmaceuticals Recent Developments/Updates
6.10 Parker Hannifin
6.10.1 Parker Hannifin Corporation Information
6.10.2 Parker Hannifin Description and Business Overview
6.10.3 Parker Hannifin Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Parker Hannifin Nanoscale Drug Delivery Devices Product Portfolio
6.10.5 Parker Hannifin Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Nanoscale Drug Delivery Devices Description and Business Overview
6.11.3 Novartis Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Novartis Nanoscale Drug Delivery Devices Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Shire Laboratories
6.12.1 Shire Laboratories Corporation Information
6.12.2 Shire Laboratories Nanoscale Drug Delivery Devices Description and Business Overview
6.12.3 Shire Laboratories Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shire Laboratories Nanoscale Drug Delivery Devices Product Portfolio
6.12.5 Shire Laboratories Recent Developments/Updates
6.13 Sanovas
6.13.1 Sanovas Corporation Information
6.13.2 Sanovas Nanoscale Drug Delivery Devices Description and Business Overview
6.13.3 Sanovas Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Sanovas Nanoscale Drug Delivery Devices Product Portfolio
6.13.5 Sanovas Recent Developments/Updates
6.14 BD
6.14.1 BD Corporation Information
6.14.2 BD Nanoscale Drug Delivery Devices Description and Business Overview
6.14.3 BD Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 BD Nanoscale Drug Delivery Devices Product Portfolio
6.14.5 BD Recent Developments/Updates
6.15 GSK
6.15.1 GSK Corporation Information
6.15.2 GSK Nanoscale Drug Delivery Devices Description and Business Overview
6.15.3 GSK Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 GSK Nanoscale Drug Delivery Devices Product Portfolio
6.15.5 GSK Recent Developments/Updates
6.16 Sanofi
6.16.1 Sanofi Corporation Information
6.16.2 Sanofi Nanoscale Drug Delivery Devices Description and Business Overview
6.16.3 Sanofi Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sanofi Nanoscale Drug Delivery Devices Product Portfolio
6.16.5 Sanofi Recent Developments/Updates
6.17 Balda
6.17.1 Balda Corporation Information
6.17.2 Balda Nanoscale Drug Delivery Devices Description and Business Overview
6.17.3 Balda Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Balda Nanoscale Drug Delivery Devices Product Portfolio
6.17.5 Balda Recent Developments/Updates
6.18 Cirtec Medical
6.18.1 Cirtec Medical Corporation Information
6.18.2 Cirtec Medical Nanoscale Drug Delivery Devices Description and Business Overview
6.18.3 Cirtec Medical Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Cirtec Medical Nanoscale Drug Delivery Devices Product Portfolio
6.18.5 Cirtec Medical Recent Developments/Updates
6.19 Nitto Avecia Pharma Services
6.19.1 Nitto Avecia Pharma Services Corporation Information
6.19.2 Nitto Avecia Pharma Services Nanoscale Drug Delivery Devices Description and Business Overview
6.19.3 Nitto Avecia Pharma Services Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Nitto Avecia Pharma Services Nanoscale Drug Delivery Devices Product Portfolio
6.19.5 Nitto Avecia Pharma Services Recent Developments/Updates
6.20 Equashield
6.20.1 Equashield Corporation Information
6.20.2 Equashield Nanoscale Drug Delivery Devices Description and Business Overview
6.20.3 Equashield Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Equashield Nanoscale Drug Delivery Devices Product Portfolio
6.20.5 Equashield Recent Developments/Updates
6.21 Peridot
6.21.1 Peridot Corporation Information
6.21.2 Peridot Nanoscale Drug Delivery Devices Description and Business Overview
6.21.3 Peridot Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Peridot Nanoscale Drug Delivery Devices Product Portfolio
6.21.5 Peridot Recent Developments/Updates
6.22 Aerogen
6.22.1 Aerogen Corporation Information
6.22.2 Aerogen Nanoscale Drug Delivery Devices Description and Business Overview
6.22.3 Aerogen Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Aerogen Nanoscale Drug Delivery Devices Product Portfolio
6.22.5 Aerogen Recent Developments/Updates
6.23 Powder Systems
6.23.1 Powder Systems Corporation Information
6.23.2 Powder Systems Nanoscale Drug Delivery Devices Description and Business Overview
6.23.3 Powder Systems Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Powder Systems Nanoscale Drug Delivery Devices Product Portfolio
6.23.5 Powder Systems Recent Developments/Updates
6.24 Flex
6.24.1 Flex Corporation Information
6.24.2 Flex Nanoscale Drug Delivery Devices Description and Business Overview
6.24.3 Flex Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Flex Nanoscale Drug Delivery Devices Product Portfolio
6.24.5 Flex Recent Developments/Updates
6.25 Bespak
6.25.1 Bespak Corporation Information
6.25.2 Bespak Nanoscale Drug Delivery Devices Description and Business Overview
6.25.3 Bespak Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Bespak Nanoscale Drug Delivery Devices Product Portfolio
6.25.5 Bespak Recent Developments/Updates
6.26 Enable Injections
6.26.1 Enable Injections Corporation Information
6.26.2 Enable Injections Nanoscale Drug Delivery Devices Description and Business Overview
6.26.3 Enable Injections Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Enable Injections Nanoscale Drug Delivery Devices Product Portfolio
6.26.5 Enable Injections Recent Developments/Updates
6.27 Insulet
6.27.1 Insulet Corporation Information
6.27.2 Insulet Nanoscale Drug Delivery Devices Description and Business Overview
6.27.3 Insulet Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Insulet Nanoscale Drug Delivery Devices Product Portfolio
6.27.5 Insulet Recent Developments/Updates
6.28 Catalent
6.28.1 Catalent Corporation Information
6.28.2 Catalent Nanoscale Drug Delivery Devices Description and Business Overview
6.28.3 Catalent Nanoscale Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Catalent Nanoscale Drug Delivery Devices Product Portfolio
6.28.5 Catalent Recent Developments/Updates
7 Nanoscale Drug Delivery Devices Manufacturing Cost Analysis
7.1 Nanoscale Drug Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nanoscale Drug Delivery Devices
7.4 Nanoscale Drug Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nanoscale Drug Delivery Devices Distributors List
8.3 Nanoscale Drug Delivery Devices Customers
9 Nanoscale Drug Delivery Devices Market Dynamics
9.1 Nanoscale Drug Delivery Devices Industry Trends
9.2 Nanoscale Drug Delivery Devices Market Drivers
9.3 Nanoscale Drug Delivery Devices Market Challenges
9.4 Nanoscale Drug Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Nanoscale Drug Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nanoscale Drug Delivery Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Nanoscale Drug Delivery Devices by Type (2023-2028)
10.2 Nanoscale Drug Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nanoscale Drug Delivery Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Nanoscale Drug Delivery Devices by Application (2023-2028)
10.3 Nanoscale Drug Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nanoscale Drug Delivery Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Nanoscale Drug Delivery Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer